HK1036461A1 - Antagonistic analogs of gh-rh inhibiting igf-i and-ii - Google Patents

Antagonistic analogs of gh-rh inhibiting igf-i and-ii

Info

Publication number
HK1036461A1
HK1036461A1 HK01107515A HK01107515A HK1036461A1 HK 1036461 A1 HK1036461 A1 HK 1036461A1 HK 01107515 A HK01107515 A HK 01107515A HK 01107515 A HK01107515 A HK 01107515A HK 1036461 A1 HK1036461 A1 HK 1036461A1
Authority
HK
Hong Kong
Prior art keywords
inhibiting igf
antagonistic analogs
antagonistic
analogs
igf
Prior art date
Application number
HK01107515A
Other languages
English (en)
Inventor
Andrew V Schally
Jozsef Varga
Marta Zarandi
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of HK1036461A1 publication Critical patent/HK1036461A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/60Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK01107515A 1998-11-25 2001-10-29 Antagonistic analogs of gh-rh inhibiting igf-i and-ii HK1036461A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/199,381 US6057422A (en) 1998-11-25 1998-11-25 Antagonistic analogs of GH-RH inhibiting IGF-I and -II
PCT/US1999/027822 WO2000031136A1 (en) 1998-11-25 1999-11-23 Antagonistic analogs of gh-rh inhibiting igf-i and -ii

Publications (1)

Publication Number Publication Date
HK1036461A1 true HK1036461A1 (en) 2002-01-04

Family

ID=22737273

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01107515A HK1036461A1 (en) 1998-11-25 2001-10-29 Antagonistic analogs of gh-rh inhibiting igf-i and-ii

Country Status (29)

Country Link
US (2) US6057422A (xx)
EP (1) EP1133522B1 (xx)
JP (1) JP2002530432A (xx)
KR (1) KR100629013B1 (xx)
CN (1) CN100422211C (xx)
AR (1) AR022392A1 (xx)
AT (1) ATE332310T1 (xx)
AU (1) AU757222B2 (xx)
BG (1) BG65137B1 (xx)
BR (1) BR9915512A (xx)
CA (1) CA2351665C (xx)
CO (1) CO5180565A1 (xx)
CZ (1) CZ20011794A3 (xx)
DE (1) DE69932255T2 (xx)
DK (1) DK1133522T3 (xx)
ES (1) ES2264279T3 (xx)
HK (1) HK1036461A1 (xx)
HU (1) HUP0105094A3 (xx)
IL (1) IL142899A0 (xx)
NO (1) NO20012489L (xx)
NZ (1) NZ511307A (xx)
PL (1) PL197471B1 (xx)
PT (1) PT1133522E (xx)
RU (1) RU2235099C2 (xx)
SK (1) SK7252001A3 (xx)
TR (1) TR200101492T2 (xx)
TW (1) TW585873B (xx)
UA (1) UA68407C2 (xx)
WO (1) WO2000031136A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060121041A1 (en) * 2001-07-12 2006-06-08 Lori Friedman Gpcs as modifiers of the irrtk p21 pathways and methods of use
US20040121407A1 (en) * 2002-09-06 2004-06-24 Elixir Pharmaceuticals, Inc. Regulation of the growth hormone/IGF-1 axis
JP2006504694A (ja) * 2002-09-18 2006-02-09 サントル・オスピタリエ・ドゥ・リュニヴェルシテ・ドゥ・モントリオール・(シー・エイチ・ユー・エム) Ghrh類似体
TW200517400A (en) * 2003-08-05 2005-06-01 Univ Tulane Antagonistic analogs of GH-RH (2003)
US8691942B2 (en) 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
MX2010010642A (es) * 2008-03-28 2011-03-29 The Univ Of Miami Nuevos analogos antagonistas, sustituidos, n- y c- terminales, de hormona liberadora de hormona de crecimiento (gh-rh).
EP2310029B1 (en) 2008-06-12 2019-04-03 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of cancer
CN102112145B (zh) 2008-06-12 2014-07-30 辛它可辛有限公司 神经内分泌病的抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
US8227421B2 (en) 2009-09-17 2012-07-24 University Of Miami Fluorinated GHRH antagonists
JP6113144B2 (ja) 2011-04-21 2017-04-12 セラテクノロジーズ・インコーポレーテッド 成長ホルモン放出因子(grf)類似体およびその使用
US9079974B2 (en) * 2011-12-21 2015-07-14 The University Of Miami GH-RH analogs with potent agonistic effects
US9855312B2 (en) 2012-12-21 2018-01-02 University Of Miami GHRH agonists for the treatment of ischemic disorders
EP2935317B1 (en) 2012-12-21 2019-03-27 University of Miami Ghrh agonists for islet cell transplantation and function and the treatment of diabetes
AU2015346277B2 (en) 2014-11-12 2020-03-26 Centre Hospitalier Universitaire De Liège Treatment of hormonal disorders of growth
WO2020163833A2 (en) 2019-02-08 2020-08-13 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659693A (en) * 1984-04-30 1987-04-21 Syntex (U.S.A.) Inc. N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides
CA2082059A1 (en) * 1990-05-04 1991-11-05 David H. Coy Synthetic grf analogs
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
US5942489A (en) * 1996-05-03 1999-08-24 The Administrators Of The Tulane Educational Fund HGH-RH(1-29)NH2 analogues having antagonistic activity

Also Published As

Publication number Publication date
AR022392A1 (es) 2002-09-04
BG65137B1 (bg) 2007-03-30
ATE332310T1 (de) 2006-07-15
BG105638A (en) 2002-01-31
PL349877A1 (en) 2002-09-23
HUP0105094A2 (hu) 2002-04-29
RU2235099C2 (ru) 2004-08-27
BR9915512A (pt) 2001-08-07
NO20012489L (no) 2001-07-04
CO5180565A1 (es) 2002-07-30
CN1328570A (zh) 2001-12-26
DE69932255T2 (de) 2007-05-31
UA68407C2 (en) 2004-08-16
AU757222B2 (en) 2003-02-06
EP1133522A1 (en) 2001-09-19
SK7252001A3 (en) 2002-02-05
CN100422211C (zh) 2008-10-01
PT1133522E (pt) 2006-11-30
DE69932255D1 (de) 2006-08-17
NO20012489D0 (no) 2001-05-21
NZ511307A (en) 2005-01-28
EP1133522B1 (en) 2006-07-05
US7026281B1 (en) 2006-04-11
CZ20011794A3 (cs) 2002-02-13
KR20010101079A (ko) 2001-11-14
TW585873B (en) 2004-05-01
DK1133522T3 (da) 2006-11-06
WO2000031136A9 (en) 2001-07-19
US6057422A (en) 2000-05-02
WO2000031136A1 (en) 2000-06-02
TR200101492T2 (tr) 2001-11-21
JP2002530432A (ja) 2002-09-17
CA2351665A1 (en) 2000-06-02
PL197471B1 (pl) 2008-04-30
KR100629013B1 (ko) 2006-09-26
AU2029100A (en) 2000-06-13
CA2351665C (en) 2008-09-02
HUP0105094A3 (en) 2002-05-28
ES2264279T3 (es) 2006-12-16
IL142899A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
HK1036461A1 (en) Antagonistic analogs of gh-rh inhibiting igf-i and-ii
SI0948541T1 (sl) PTHrP analogi
PL331985A1 (en) Substituted n-[(amino-imino methy- or amino-methyl-)phenyl]-propylamides
EP1078023A4 (en) LUMINESCENT COMPOUNDS
GB9800795D0 (en) Prevention of multiple use of limited use devices
IL173201A0 (en) Antagonistic analogs of gh-rh (2003)
AP2001002078A0 (en) Crystalline forms of et02c-ch2(r)cgl-aze-pab-oh
EP1043873A4 (en) CIRCUIT FOR ACHIEVING SYNCHRONIZATION
PL345037A1 (en) Cyclic somatostatin analogs
SI1133522T1 (sl) Antagonisticni analogi GH-RH, ki inhibirajo IGF-Iin -II
PL337612A1 (en) Crystalline form of roxyfiban
GB9923017D0 (en) Walking aid
EP1131343A4 (en) HYDROPHILIC SOMATOSTATIN ANALOGUE
GB2338849B (en) Voltage controlled oscillator circuit
GB9921429D0 (en) Ring oscillator
TW454513U (en) Structure of switching cover for fastening ring of nipple
TW346102U (en) Improved structure for cup cover of Pao-Te bottle
ZA9861B (en) Analogs of parathyroid hormone
TW355036U (en) Improvement of sucking cup
GB9908820D0 (en) Walking aid
ZA984042B (en) Ampoule accessory
HU9802350D0 (en) Invention for the usage of time
TW502873U (en) Improved structure of SMT rectifying diode
SI1107980T1 (en) CRYSTALLINE FORMS OF EtO2C-CH2-(R)Cgl-Aze-Pab-OH
TW371469U (en) Container of palace-lantern-shape

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091123